Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Myelodysplastic Syndromes 14Hodgkin Disease 10Hematologic Neoplasms 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Leukemia 8Lymphoma, Non-Hodgkin 7Myeloproliferative Disorders 6Multiple Myeloma 6Leukemia, Lymphocytic, Chronic, B-Cell 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Lymphoma 5Leukemia, Myelomonocytic, Chronic 5Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Prolymphocytic 3Congenital Abnormalities 3Blast Crisis 3Anemia, Aplastic 3Thrombocythemia, Essential 2Sezary Syndrome 2Recurrence 2

Interventions

Temozolomide 1Radiotherapy, Intensity-Modulated 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Glioblastoma × Mycophenolic Acid × 90 days × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡